Global Liquid Biopsy Market is anticipated to reach US$ 1.75 billion by 2021
©
According to the report "Liquid Biopsy Market", published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021.
View Report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Get free sample report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented By Type, Diagnostic Approach, End Users and Region.
1. By Cancer Type:
• Lung Cancer
• Pancreatic Cancer
• Leukemia
• Other Visceral Cancers
2. By Sample Type:
• Blood
• Urine
• Plasma
• Saliva
• Cerebrospinal
3. By Diagnostic Approach:
• Circulating Tumour cells (CTC)
• Circulating Tumour DNA (ctDNA)
• RNA in exosomes
• Extra-Cellular Vesicles
4. By End Users:
• Reference Laboratories
• Hospital/Physician Laboratories
• Academic and Research Centers
• Other End Users
5. By Geography:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East and Africa
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Abhishek Shukla
Sales Manager
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 9985550206
Mail: abhishek@marketdataforecast.com
View Report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Get free sample report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented By Type, Diagnostic Approach, End Users and Region.
1. By Cancer Type:
• Lung Cancer
• Pancreatic Cancer
• Leukemia
• Other Visceral Cancers
2. By Sample Type:
• Blood
• Urine
• Plasma
• Saliva
• Cerebrospinal
3. By Diagnostic Approach:
• Circulating Tumour cells (CTC)
• Circulating Tumour DNA (ctDNA)
• RNA in exosomes
• Extra-Cellular Vesicles
4. By End Users:
• Reference Laboratories
• Hospital/Physician Laboratories
• Academic and Research Centers
• Other End Users
5. By Geography:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East and Africa
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Abhishek Shukla
Sales Manager
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 9985550206
Mail: abhishek@marketdataforecast.com